Biosimilars Insurance Coverage and Processing Presentation 
Express Pharma
MARCH 16, 2025
On the global stage, AI and Machine Learning (ML) drove drug discovery and process optimisation, especially as large-scale pharma companies adopted AI for precision medicine. Building sophisticated laboratories, recruiting scientific talent, and collaborating with global research institutions are essential steps in this process.
Pharma in Brief
FEBRUARY 2, 2022
In a recently published discussion paper , an Advisory Panel (the Panel ) convened by the Canadian Agency for Drugs and Technologies in Health ( CADTH ) presents a proposed framework for a potential pan-Canadian formulary. In Canada, coverage for prescription drugs exists through an array of public and private drug plans. Background.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Big Molecule Watch
AUGUST 25, 2023
Congress left Medicare drug pricing to the drug manufacturers, pharmacies, and insurance plan sponsors to determine, and expressly prohibited the government from “interfering” in those private price negotiations under the so-called “Non-Interference Clause” of the Medicare Modernization Act of 2003.
Putting Patients First Blog
JANUARY 27, 2025
However, the scope and complexity of the proposed rule may present implementation challenges. Coverage of Anti-Obesity Medications (AOMs) The NHC applauds CMS for aligning with the medical community and proposing to recognize obesity as a chronic disease and allow Medicare Part D coverage for AOMs.
PharmaShots
JUNE 28, 2023
Revenue Analysis1 PharmaShots presents a 5-year analysis of Enbrel sales. Some of the alternative drugs for Enbrel include: Enbrel’s Biosimilars6 As Enbrel has a long journey in the market it is already facing competition from biosimilars in the US and other countries. This list is not an exhaustive list.
Expert insights. Personalized for you.
98 
Let's personalize your content